Vext Science Stock Performance
| VEXTF Stock | USD 0.14 0.01 7.69% |
The entity has a beta of -2.06, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Vext Science are expected to decrease by larger amounts. On the other hand, during market turmoil, Vext Science is expected to outperform it. At this point, Vext Science has a negative expected return of -0.22%. Please make sure to validate Vext Science's total risk alpha, as well as the relationship between the skewness and day median price , to decide if Vext Science performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vext Science has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -27.1 M |
Vext |
Vext Science Relative Risk vs. Return Landscape
If you would invest 18.00 in Vext Science on September 2, 2024 and sell it today you would lose (4.00) from holding Vext Science or give up 22.22% of portfolio value over 90 days. Vext Science is currently producing negative expected returns and takes up 5.8697% volatility of returns over 90 trading days. Put another way, 52% of traded otc stocks are less volatile than Vext, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Vext Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vext Science's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Vext Science, and traders can use it to determine the average amount a Vext Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0381
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VEXTF |
Estimated Market Risk
| 5.87 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vext Science is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vext Science by adding Vext Science to a well-diversified portfolio.
Vext Science Fundamentals Growth
Vext OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Vext Science, and Vext Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vext OTC Stock performance.
| Return On Equity | 0.0931 | |||
| Return On Asset | 0.0719 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 28.43 M | |||
| Shares Outstanding | 72.67 M | |||
| Price To Earning | 4.88 X | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.31 X | |||
| Revenue | 37.24 M | |||
| EBITDA | 12.34 M | |||
| Cash And Equivalents | 1.54 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 7.43 M | |||
| Debt To Equity | 0.21 % | |||
| Book Value Per Share | 0.47 X | |||
| Cash Flow From Operations | 11.68 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 83.7 M | |||
About Vext Science Performance
By analyzing Vext Science's fundamental ratios, stakeholders can gain valuable insights into Vext Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vext Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vext Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona . Vext Science is traded on OTC Exchange in the United States.Things to note about Vext Science performance evaluation
Checking the ongoing alerts about Vext Science for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Vext Science help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vext Science generated a negative expected return over the last 90 days | |
| Vext Science has high historical volatility and very poor performance | |
| Vext Science has some characteristics of a very speculative penny stock | |
| About 19.0% of the company outstanding shares are owned by insiders |
- Analyzing Vext Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vext Science's stock is overvalued or undervalued compared to its peers.
- Examining Vext Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vext Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vext Science's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Vext Science's otc stock. These opinions can provide insight into Vext Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vext OTC Stock analysis
When running Vext Science's price analysis, check to measure Vext Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vext Science is operating at the current time. Most of Vext Science's value examination focuses on studying past and present price action to predict the probability of Vext Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vext Science's price. Additionally, you may evaluate how the addition of Vext Science to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |